These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
801 related articles for article (PubMed ID: 27062198)
21. Synthesis of N-hydroxycinnamides capped with a naturally occurring moiety as inhibitors of histone deacetylase. Huang WJ; Chen CC; Chao SW; Lee SS; Hsu FL; Lu YL; Hung MF; Chang CI ChemMedChem; 2010 Apr; 5(4):598-607. PubMed ID: 20209563 [TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors. Liu R; Wang J; Tang W; Fang H Bioorg Med Chem; 2016 Apr; 24(7):1446-54. PubMed ID: 26907204 [TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents. Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876 [TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors. Jiang BE; Hu J; Liu H; Liu Z; Wen Y; Liu M; Zhang HK; Pang X; Yu LF Eur J Med Chem; 2022 Jan; 227():113893. PubMed ID: 34656899 [TBL] [Abstract][Full Text] [Related]
25. SAHA Capture Compound--a novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders. Fischer JJ; Michaelis S; Schrey AK; Diehl A; Graebner OY; Ungewiss J; Horzowski S; Glinski M; Kroll F; Dreger M; Koester H Proteomics; 2011 Oct; 11(20):4096-104. PubMed ID: 21898820 [TBL] [Abstract][Full Text] [Related]
26. Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents. Cai J; Wei H; Hong KH; Wu X; Zong X; Cao M; Wang P; Li L; Sun C; Chen B; Zhou G; Chen J; Ji M Bioorg Med Chem; 2015 Jul; 23(13):3457-71. PubMed ID: 25953722 [TBL] [Abstract][Full Text] [Related]
27. Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities. Chao SW; Chen LC; Yu CC; Liu CY; Lin TE; Guh JH; Wang CY; Chen CY; Hsu KC; Huang WJ Eur J Med Chem; 2018 Jan; 143():792-805. PubMed ID: 29223096 [TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide. Canzoneri JC; Chen PC; Oyelere AK Bioorg Med Chem Lett; 2009 Dec; 19(23):6588-90. PubMed ID: 19854643 [TBL] [Abstract][Full Text] [Related]
29. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif. Guan P; Wang L; Hou X; Wan Y; Xu W; Tang W; Fang H Bioorg Med Chem; 2014 Nov; 22(21):5766-75. PubMed ID: 25311567 [TBL] [Abstract][Full Text] [Related]
30. Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next. Thaler F; Mercurio C ChemMedChem; 2014 Mar; 9(3):523-6. PubMed ID: 24730063 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors. Zhang S; Huang W; Li X; Yang Z; Feng B Chem Biol Drug Des; 2015 Oct; 86(4):795-804. PubMed ID: 25763653 [TBL] [Abstract][Full Text] [Related]
32. Development of hydroxamate-based histone deacetylase inhibitors containing 1,2,4-oxadiazole moiety core with antitumor activities. Yang F; Shan P; Zhao N; Ge D; Zhu K; Jiang CS; Li P; Zhang H Bioorg Med Chem Lett; 2019 Jan; 29(1):15-21. PubMed ID: 30455152 [TBL] [Abstract][Full Text] [Related]
33. Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition. King K; Hauser AT; Melesina J; Sippl W; Jung M Molecules; 2018 Feb; 23(2):. PubMed ID: 29393896 [TBL] [Abstract][Full Text] [Related]
34. Novel Conjugated Quinazolinone-Based Hydroxamic Acids: Design, Synthesis and Biological Evaluation. Vu TK; Thanh NT; Minh NV; Linh NH; Thao NTP; Nguyen TTB; Hien DT; Chinh LV; Duc TH; Anh LD; Hai PT Med Chem; 2021; 17(7):732-749. PubMed ID: 32310052 [TBL] [Abstract][Full Text] [Related]
35. The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker. Yang F; Zhao N; Hu Y; Jiang CS; Zhang H Chem Biodivers; 2020 Jan; 17(1):e1900427. PubMed ID: 31793143 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents. Hieu DT; Anh DT; Tuan NM; Hai PT; Huong LT; Kim J; Kang JS; Vu TK; Dung PTP; Han SB; Nam NH; Hoa ND Bioorg Chem; 2018 Feb; 76():258-267. PubMed ID: 29223029 [TBL] [Abstract][Full Text] [Related]
37. Coumarin-suberoylanilide hydroxamic acid as a fluorescent probe for determining binding affinities and off-rates of histone deacetylase inhibitors. Singh RK; Mandal T; Balasubramanian N; Cook G; Srivastava DK Anal Biochem; 2011 Jan; 408(2):309-15. PubMed ID: 20816742 [TBL] [Abstract][Full Text] [Related]
38. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects. Liao V; Liu T; Codd R Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors. Huang WJ; Chen CC; Chao SW; Yu CC; Yang CY; Guh JH; Lin YC; Kuo CI; Yang P; Chang CI Eur J Med Chem; 2011 Sep; 46(9):4042-9. PubMed ID: 21712146 [TBL] [Abstract][Full Text] [Related]
40. A cyclodextrin-capped histone deacetylase inhibitor. Amin J; Puglisi A; Clarke J; Milton J; Wang M; Paranal RM; Bradner JE; Spencer J Bioorg Med Chem Lett; 2013 Jun; 23(11):3346-8. PubMed ID: 23591111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]